Company: Biopure
Industry: Biotech
Transaction: $20,000,000 Private Placement
RMG’s Role: Joint Advisor securing financing through RMG’s institutional investor network

The mission of Biopure Corporation (NASDAQ: BPUR) is to introduce revolutionary new drugs that deliver lifesaving oxygen. Using it’s patented and proprietary technology, Biopure has pioneered the development and manufacture of oxygen therapeutics, a new class of pharmaceuticals that are intravenously administered to deliver oxygen to the body’s tissues. The company’s products represent a new Oxygen Bridge™ treatment approach for managing patients’ oxygen requirements in potential medical applications associated with ischemia or acute anemia.